Company
Letter from the Chair
Letter from the CEO
2024 Highlights
Investor Information
Our Priorities in 2024
Our People and Culture
Our Businesses
Group Operations
Biologics
Small Molecules
Cell & Gene
Capsules & Health Ingredients
Sustainability
Financials
Remuneration
Governance
Creating Value in 2024
Our Businesses
Our Approach to Sustainability
Financial Highlights
Corporate Governance Overview
Our Businesses
Group Operations
Biologics
Small Molecules
Cell & Gene
Capsules & Health Ingredients
Download Section PDF
